Abstract
Giant cell tumor (GCT) of bone is a well-vascularized tissue made up of a network of spindle-shaped mononuclear stromal cells that represent the proliferating pattern, round mononuclear monocytes, and multinucleated giant cells.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Bibliography
Balla P, Moskovszky L, Sapi Z, Forsyth R, Knowles H, Athanasou NA, Szendroi M, Kopper L, Rajnai H, Pinter F, Petak I, Benassi MS, Picci P, Conti A, Krenacs T (2011) Epidermal growth factor receptor signalling contributes to osteoblastic stromal cell proliferation, osteoclastogenesis and disease progression in giant cell tumour of bone. Histopathology 59(3):376–389
Broadhead ML, Clark JC, Dass CR, Choong PF, Myers DE (2011) Therapeutic targeting of osteoclast function and pathways. Expert Opin Ther Targets 15(2):169–181
Conti A, Rodriguez GC, Chiechi A, Blazquez RM, Barbado V, Krènacs T, Novello C, Pazzaglia L, Quattrini I, Zanella L, Picci P, De Alava E, Benassi MS (2011) Identification of potential biomarkers for giant cell tumor of bone using comparative proteomics analysis. Am J Pathol 178(1):88–97
Fujisaki K, Tanabe N, Suzuki N, Mitsui N, Oka H, Ito K, Maeno M (2006) The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells. Life Sci 78(17):1975–1982
Gamberi G, Benassi MS, Ragazzini P, Pazzaglia L, Ponticelli F, Ferrari C, Balladelli A, Mercuri M, Gigli M, Bertoni F, Picci P (2004) Proteases and interleukin-6 gene analysis in 92 giant cell tumors of bone. Ann Oncol 15(3):498–503
Gorunova L, Vult von Steyern F, Storlazzi CT, Bjerkehagen B, Follerås G, Heim S, Mandahl N, Mertens F (2009) Cytogenetic analysis of 101 giant cell tumors of bone: nonrandom patterns of telomeric associations and other structural aberrations. Genes Chromosomes Cancer 48(7):583–602
Heymann D (2012) Anti-RANKL therapy for bone tumours. Basic, pre-clinical and clinical evidence. J Bone Oncol 1:2–11
Mosakhani N, Pazzaglia L, Benassi MS, Borze I, Quattrini I, Picci P, Knuutila S (2013) MicroRNA expression profiles in metastatic and non-metastatic giant cell tumor of bone. Histol Histopathol 28(5):671–8
Moskovszky L, Szuhai K, Krenács T, Hogendoorn PC, Szendroi M, Benassi MS, Kopper L, Füle T, Sápi Z (2009) Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array-CGH analysis. Genes Chromosomes Cancer 48(6):468–479
Pazzaglia L, Conti A, Chiechi A, Novello C, Magagnoli G, Astolfi A, Pession A, Krenacs T, Alberghini M, Picci P, Benassi MS (2010) Differential gene expression in classic giant cell tumours of bone: Tenascin C as biological risk factor for local relapses and metastases. Histopathology 57(1):59–72
Thomas DM, Skubitz KM (2009) Giant cell tumour of bone. Curr Opin Oncol 21(4):338–344
Wittrant Y, Théoleyre S, Chipoy C, Padrines M, Blanchard F, Heymann D, Rédini F (2004) RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis. Biochim Biophys Acta 1704(2):49–57
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Benassi, M.S. (2014). Biology of Giant Cell Tumor. In: Picci, P., Manfrini, M., Fabbri, N., Gambarotti, M., Vanel, D. (eds) Atlas of Musculoskeletal Tumors and Tumorlike Lesions. Springer, Cham. https://doi.org/10.1007/978-3-319-01748-8_21
Download citation
DOI: https://doi.org/10.1007/978-3-319-01748-8_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-01747-1
Online ISBN: 978-3-319-01748-8
eBook Packages: MedicineMedicine (R0)